Skip to main content
Fig. 57 (abstract P339). | Journal for ImmunoTherapy of Cancer

Fig. 57 (abstract P339).

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Fig. 57 (abstract P339).

MVA∆E3L-hFlt3L is more efficacious than MVA∆E3L. Shown here are tumor volumes of injected (a, c and e) and non-injected tumors (b, d, and f). (g) A Kaplan-Meier survival curve of tumor-bearing mice (B16-F10 cells) injected with PBS (filled circles), MVA∆E3L (filled squares), or MVAΔE3L-hFlt3L (filled triangles). **, p < 0.01 (MVA∆E3L vs. PBS group); **, p < 0.01 (MVA∆E3L-hFlt3L vs. MVA∆E3L group). (H) A Kaplan-Meier survival curve of tumor-bearing mice (B16-F10 cells) successfully treated with MVA∆E3L-hFlt3L vs naive mice challenged with a lethal dose of MC38 cells intradermally (1 x 10e5)

Back to article page